Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.33%
#3 Black Phoenix Black Phoenix +35.18%
#4 Velvet Velvet +25.69%
#5 Akedo Akedo +22.89%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#7 DoubleZero DoubleZero +17.26%
#8 Fake World Assets Fake World Assets +16.79%
#9 Palladium Network Palladium Network +14.94%
#10 clBTC clBTC +11.73%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
OKYO Pharma Limited OKYO Pharma Limited

OKYO Pharma Limited

OKYO
Rank in Stocks #39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
Share Price
$0.01904982
Last synced: 2023-05-19
Market Cap
$316.00K
Change (1 day)
-17.05%
Change (1 year)
0.00%
Country
GB
Trade OKYO Pharma Limited (OKYO)

Category

Healthcare
Earnings for OKYO Pharma Limited (OKYO)
Earnings in 2026 TTM: 0
According to OKYO Pharma Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for OKYO Pharma Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE